Overexpression of aldose reductase in human cancer tissues

Medical Science Monitor

Volumn 12, Issue 12, 2006, Pages

  Saraswat, Megha ^a   Mrudula, Tiruvalluru ^a   Kumar, Putcha Uday ^a   Suneetha, Allanki ^b   Rao, Thamineedi Subramanyeshwara ^b   Srinivasulu, Mukta ^b   Reddy, Geereddy Bhanuprakash ^a  

^a NATIONAL INSTITUTE OF NUTRITION   (India)

^b MNJ Institute of Oncology   (India)

Author keywords

Aldose reductase; Breast; Cancer; Cervix; Chemotherapy; Detoxification; Drug resistance; Ovary; Polyol pathway; Rectum

Indexed keywords

ALDEHYDE REDUCTASE;

ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER TISSUE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; OVARY CANCER; OVARY TUMOR; PROTEIN EXPRESSION; RECTUM CANCER; RECTUM TUMOR; UTERINE CERVIX CANCER; UTERINE CERVIX TUMOR;

ALDEHYDE REDUCTASE; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NEOPLASMS; OVARIAN NEOPLASMS; RECTAL NEOPLASMS; UTERINE CERVICAL NEOPLASMS;

EID: 33845499493     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bhatnagar A, Srivastava SK: Aldose reductase: congenial and injurious profiles of an enigmatic enzyme. Biochem Med Metab Biol, 1992; 48: 91-121
2. Chylack LT, Friend J: Intermediary metabolism of the lens: a historical perspective. Exp Eye Res, 1990; 50: 575-82
3. Kador PF: The role of aldose reductase in the development of diabetic complications. Med Res Rev, 1998; 8: 325-52
4. Morrison AD, Clements RS, Travis SB et al: Glucose utilization by the polyol pathway in human erythrocytes. Biochem Biophys Res Commun, 1970; 40: 199-205
5. Gonzalez RG, Barnet P, Aguayo J et al: Direct measurement of polyol pathway activity in the ocular lens. Diabetes, 1984; 33: 196-99
6. Vander Jagt DL, Hunsaker LA: Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase. Chem Biol Interact, 2003; 143-144: 341-51
7. Rittner HL, Hafner V, Klimiuk PA et al: Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J Clin Invest, 1999; 103: 1007-13
8. He Q, Khanna P, Srivastava S et al: Reduction of 4-hydroxynonenal and 4-hydroxyhexenal by retinal aldose reductase. Biochem Biophys Res Commun, 1998; 247: 719-22
9. Takahashi M, Fujii J, Miyoshi E et al: Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines: implication in detoxification of cytotoxic aldehydes. Int J Cancer, 1995; 62: 749-754
10. Zeindl-Eberhart E, Jungblut PR, Otto A, Rabes HM: Identification of tumor-associated protein variants during rat hepatocarcinogenesis. J Biol Chem, 1994; 269: 14589-94
11. Cao D, Fan ST, Chung SS: Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem, 1998; 273: 11429-35
12. Lee KW, Ko BC, Jiang Z et al: Overexpression of aldose reductase in liver cancers may contribute to drug resistance. Anticancer Drugs, 2001; 12: 129-32
13. Lee EK, Regenold WT, Shapiro P: Inhibition of aldose reductase enhances HeLa cell sensitivity to chemotherapeutic drugs and involves activation of extracellular signal-regulated kinases. Anticancer Drugs, 2002; 13: 859-68
14. Fukumoto S, Yamauchi N, Moriguchi H et al: Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas. Clin Cancer Res, 2005; 11: 1776-85
15. Kang ES, Kim HJ, Paek KS et al: Phorbol ester up-regulates aldose reductase expression in A549 cells: a potential role for aldose reductase in cell cycle modulation. Cell Mol Life Sci, 2005; 62: 1146-55
16. Petrash JM, Harter TM, Devine CS et al: Involvement of cysteine residues in catalysis and inhibition of human aldose reductase. Site-directed mutagenesis of Cys-80, -298, and -303. J Biol Chem, 1992; 267: 24833-40
17. Harlow E, Lane D: In Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory Publications New York, 1988
18. Suryanarayana P, Kumar PA, Saraswat M et al: Inhibition of aldose reductase by tannoid principles of Emblica Officinalis: Implications for the prevention of sugar cataract. Mol Vis, 2004; 10: 148-154
19. Srivastava SK, Hair GA, Das B: Activated and unactivated forms of human erythrocyte aldose reductase. Proc Natl Acad Sci USA, 1985; 82: 7222-26
20. Srivastava SK, Ansari NH, Hair GA et al: Hyperglycemia-induced activation of human erythrocyte aldose reductase and alterations in kinetic properties. Biochem Biophys Acta 1986; 870: 302-11
21. Suryanarayana P, Krishnaswamy K, Reddy GB: Effect of curcumin on galactose-induced cataractogenesis in rats. Mol Vis, 2003; 9: 223-30
22. Suryanarayana P, Kumar PA, Mrudula T et al: Curcumin and turmeric delay diabetic cataract in rats. Invest Ophthalmol Vis Sci, 2005; 46: 2092-99